Assyro AI

Orange Book product · Brand (NDA)

EMEND

APREPITANT

Brand (NDA)NDA 021549DISCN MSD

At a glance

Jun 30, 2006

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 30, 2006

    20 yr 3 mo ago

  2. Today

  3. Patent 8258132 expires

    Listed drug product patent expiration.

    Sep 26, 2027

    in 1 yr 3 mo

  4. Patent 8258132 expires

    Listed drug product patent expiration.

    Sep 26, 2027

    in 1 yr 3 mo

Pharmaceutical detail

Active ingredient

APREPITANT

Strength

40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 021549

Product number

003

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8258132Sep 26, 2027in 1 yr 3 mo
ProductU-901
8258132Sep 26, 2027in 1 yr 3 mo
ProductU-1743
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.